Antacid Market Research Report By Type (Liquid Antacids, Tablet Antacids, Powder Antacids, Chewable Antacids), By Active Ingredient (Aluminum Hydroxide, Magnesium Hydroxide, Sodium Bicarbonate, Calcium Carbonate, Potassium Citrate), By Application (Immediate Relief, Long-Term Relief, Heartburn, Indigestion, Acid Reflux), By Distribution Channel (Pharmacies, Online Retailers, Supermarkets, Convenience Stores, Healthcare Professionals) and By Regional (North America, Europe, South America, Asia Pacific, Middle East and Africa) - Forecast to 2

Antacid Market Overview

As per MRFR analysis, the Antacid Market Size was estimated at 18.23 (USD Billion) in 2023. The Antacid Market Industry is expected to grow from 18.99 (USD Billion) in 2024 to 24.35 (USD Billion) by 2032. The Antacid Market CAGR (growth rate) is expected to be around 2.80% during the forecast period (2024 - 2032).

Key Antacid Market Trends Highlighted

The demand for antacids is primarily driven by the increasing prevalence of gastrointestinal disorders such as heartburn, acidity, and indigestion. Sedentary lifestyles, irregular eating habits, and stress all contribute to digestive issues, fueling the market growth. Moreover, the rising awareness about the importance of gut health and the availability of over-the-counter antacids further stimulate market expansion.

The market presents opportunities for innovation in delivery formats, such as chewable tablets, liquids, and effervescent powders. Additionally, the development of antacids with natural ingredients and herbal remedies offers potential growth avenues. Exploring the potential of antacids in pet care and targeting specific demographics, such as the geriatric population, can also uncover new market segments.

The antacid market has witnessed a shift towards antacids with a combination of ingredients, such as magnesium, calcium, and aluminum, as they provide faster and more comprehensive relief. Furthermore, the growing popularity of antacids containing prebiotics and probiotics has emerged as a trend, catering to consumers seeking holistic solutions for digestive health.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Antacid Market Drivers

Increasing Prevalence of Gastrointestinal Disorders

The main driver of the Antacid Market is the growing incidence of gastrointestinal disorders such as heartburn, indigestion, and acid reflux. These disorders are triggered by medical conditions, unhealthy diet, stress, and certain medications. Since stomach disorders are on the spike, there is a coherent tendency for the significant growth of demand from the side of the patient population. The Antacid Market Industry will grow at a moderate pace for the period of the forecast due to the increasing prevalence of gastrointestinal disorders and increased awareness of care for the disorder.

Lifestyle Changes and Dietary Habits

Changing lifestyles and dietary habits are contributing to the growth of the Antacid Market. The consumption of processed foods, spicy dishes, and carbonated beverages can lead to stomach discomfort and heartburn. Additionally, irregular eating patterns and stress can also exacerbate these conditions. As people become more aware of the negative effects of unhealthy diets and lifestyles, the demand for antacids is likely to increase.

Rising Healthcare Expenditure and Accessibility

Other factors promoting the growth of the Antacid Market include increasing healthcare expenditures and better access to healthcare services. Governments and insurance companies have become invested in providing better healthcare infrastructure and running programs, resulting in wider accessibility and affordability of antacids by the whole population. It is expected that the demand for antacids will rise due to higher accessibility in emerging markets where expenditures on healthcare are growing the fastest.

Antacid Market Segment Insights:

Antacid Market Type Insights

The Antacid Market is divided by type into liquid antacids, tablet antacids, powder antacids and chewable antacids. Liquid antacids are by far the most used type, as they are the easiest to use, conveniently available and do not require any special conditions to be administered. They are always over-the-counter preparations and are most popular among consumers who suffer from frequent heartburn or indigestion. Tablet antacids are a more convenience-packed version of the liquid Biospy ones with the same active ingredients.

Tablets are used for more severe heartburns and indigestion issues with higher concentrations and possible prescription forms. Different from table antacids powder ones are, although more rare, also used and effective in neutralizing stomach acid. Powder antacids are usually mixed with water. Chewable antacids are much more convenient and preferred especially for those who do not like taking something liquid. They are offered in various tastes and can also be aimed at children as well as grown-ups with difficulties in pill- and tablet-swallowing. This is first of all because of the rising prevalence of gastrointestinal or related diseases, such as heartburn and indigestion, and, secondly, the growth of OTC drugs and increased awareness of gut health.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Antacid Market Active Ingredient Insights

The Antacid Market segmentation by Active Ingredient comprises Aluminum Hydroxide, Magnesium Hydroxide, Sodium Bicarbonate, Calcium Carbonate, and Potassium Citrate. Among these, Aluminum Hydroxide and Magnesium Hydroxide collectively accounted for over 60% of the market revenue in 2023. Aluminum Hydroxide, being the most widely used antacid, is expected to maintain its dominance throughout the forecast period. The growing prevalence of gastroesophageal reflux disease (GERD) and peptic ulcer disease (PUD) is anticipated to drive the demand for Aluminum Hydroxide-based antacids. Additionally, Magnesium Hydroxide is gaining popularity due to its ability to neutralize stomach acid and provide fast relief from heartburn and indigestion. The growing awareness about the benefits of antacids is expected to fuel the growth of the Antacid Market in the coming years.

Antacid Market Application Insights

The Antacid Market segmentation by Application includes Immediate Relief, Long-Term Relief, Heartburn, Indigestion, and Acid Reflux. The Immediate Relief segment accounted for the largest market share, around USD 4.5 billion in 2023, and is anticipated to grow at a CAGR of 2.8% during the forecast period. The Long-Term Relief segment is projected to witness a CAGR of 3.2% over the forecast period. Heartburn and Indigestion are expected to grow at a CAGR of 2.9% and 2.7%, respectively, during the forecast period. Acid Reflux is projected to grow at a CAGR of 2.6%. The growth of the Antacid Market is primarily attributed to the increasing prevalence of gastrointestinal disorders, such as acid reflux and heartburn, along with the growing awareness of antacids among consumers.

Antacid Market Distribution Channel Insights

The distribution channel segment plays a crucial role in the Antacid Market, shaping market dynamics and influencing revenue generation. Pharmacies emerged as the dominant distribution channel, accounting for a significant share of the market in 2023. Their extensive reach, accessibility, and trusted reputation among consumers drive their dominance. Online retailers are rapidly gaining ground, leveraging e-commerce platforms to offer convenience, competitive pricing, and a wide product range. Supermarkets and convenience stores cater to impulse purchases and provide easy access to antacids for immediate relief. Healthcare professionals, including doctors and pharmacists, serve as valuable distribution channels, providing expert advice and recommendations to patients. Understanding the strengths and preferences of each distribution channel is essential for manufacturers to optimize their strategies and maximize market penetration.

Antacid Market Regional Insights

The Antacid Market segmentation by region offers valuable insights into the market's geographic performance. North America held the largest market share in 2023 and is projected to maintain its dominance throughout the forecast period. The region's large population, high disposable income, and prevalence of gastrointestinal disorders contribute to its significant market size. Europe is another key market, driven by increasing healthcare expenditure and rising awareness about antacid usage. The Asia-Pacific region is expected to witness substantial growth, owing to the increasing prevalence of digestive issues, growing population, and expanding healthcare infrastructure. South America and the Middle East and Africa (MEA) regions are also expected to contribute to the overall market growth, albeit at a slower pace.

Source: Primary Research, Secondary Research, Market Research Future Database and Analyst Review

Antacid Market Key Players And Competitive Insights:

Major players in Antacid Market industry are constantly innovating and developing new products to meet the evolving needs of consumers. Leading Antacid Market players are focusing on expanding their global presence through acquisitions and partnerships. The Antacid Market development is being driven by the increasing prevalence of gastrointestinal disorders and the growing demand for over-the-counter medications. The Antacid Market Competitive Landscape is characterized by the presence of both global and regional players. Among the leading players in the Antacid Market, GlaxoSmithKline holds a significant market share. The company offers a wide range of antacid products under the brand name Tums.

Tums is one of the most recognized and trusted antacid brands in the world. GlaxoSmithKline has a strong distribution network and a loyal customer base. The company is continuously investing in research and development to develop new and innovative antacid products. One of the key competitors in the Antacid Market is Bayer. The company offers a range of antacid products under the brand name Alka-Seltzer. Alka-Seltzer is a well-known and popular antacid brand. Bayer has a strong presence in both developed and emerging markets. The company is focusing on expanding its market share through product innovation and strategic acquisitions.

Key Companies in the Antacid Market Include:

• Teva Pharmaceutical Industries Ltd.
• Johnson Johnson Consumer Inc.
• Bayer AG
• Merck Co., Inc.
• Procter Gamble Company
• GlaxoSmithKline plc
• Mentholatum Company, In
• Reckitt Benckiser
• Daiichi Sankyo Company, Limited
• AstraZeneca Plc
• Sanofi Aventis
• Abbott Laboratories
• Novartis
• Boehringer Ingelheim GmbH

Antacid Market Industry Developments

• Q2 2024: TUMS® Launches New TUMS+ Heartburn+Sleep Support Chewable Tablets TUMS®, a leading antacid brand, announced the launch of TUMS+ Heartburn+Sleep Support, a chewable tablet combining antacid relief with melatonin to address both heartburn and occasional sleeplessness. The product became available nationwide in the United States in April 2024.
• Q2 2024: GSK Consumer Healthcare Announces U.S. Launch of New Liquid Antacid Under Tums Brand GSK Consumer Healthcare introduced a new liquid antacid formulation under its Tums brand, expanding its product portfolio to address consumer demand for alternative antacid delivery formats. The product was made available in major U.S. retail outlets in May 2024.
• Q2 2024: Dr. Reddy’s Laboratories Launches Famotidine Tablets USP, 20 mg and 40 mg, in the U.S. Market Dr. Reddy’s Laboratories announced the launch of Famotidine Tablets USP, 20 mg and 40 mg, an over-the-counter antacid product, in the United States following approval from the U.S. Food and Drug Administration in April 2024.
• Q3 2024: Sanofi Appoints New Head of Consumer Healthcare Division Sanofi announced the appointment of a new executive to lead its Consumer Healthcare division, which includes the company’s antacid brands, as part of a broader leadership restructuring in July 2024.
• Q3 2024: Perrigo Opens New Manufacturing Facility for OTC Antacids in Michigan Perrigo Company plc inaugurated a new manufacturing facility in Michigan dedicated to the production of over-the-counter antacid products, aiming to increase capacity and meet growing demand in North America in August 2024.
• Q3 2024: Reckitt Benckiser Launches Gaviscon Dual Action Chewable Tablets in Canada Reckitt Benckiser announced the Canadian launch of Gaviscon Dual Action Chewable Tablets, expanding its antacid product line in North America in July 2024.
• Q4 2024: GSK Receives FDA Approval for New Pepcid Complete Formulation GSK received U.S. FDA approval for a new formulation of Pepcid Complete, an over-the-counter antacid, in October 2024, enabling the company to offer enhanced acid relief options to consumers.
• Q4 2024: Bayer Sells Antacid Brand Talcid to Stada Arzneimittel Bayer AG completed the sale of its antacid brand Talcid to Stada Arzneimittel as part of a portfolio optimization strategy in November 2024.
• Q1 2025: Sun Pharma Launches Generic Ranitidine Tablets in U.S. Market Sun Pharmaceutical Industries announced the launch of generic Ranitidine Tablets, an antacid product, in the U.S. market in January 2025 following regulatory clearance.
• Q1 2025: Procter & Gamble Expands Prilosec OTC Production Capacity in Ohio Procter & Gamble announced the expansion of its Prilosec OTC production facility in Ohio to meet increased demand for over-the-counter antacid products in February 2025.
• Q2 2025: Takeda and Alkem Laboratories Announce Strategic Partnership for Antacid Distribution in Asia Takeda and Alkem Laboratories entered into a strategic partnership to distribute Takeda’s antacid products across select Asian markets, aiming to strengthen their presence in the region in May 2025.
• Q2 2025: Pfizer Launches New Fast-Dissolving Antacid Tablets in Europe Pfizer announced the launch of a new line of fast-dissolving antacid tablets in several European countries, targeting consumers seeking rapid relief from heartburn and indigestion in June 2025.

Antacid Market Segmentation Insights

Antacid Market Type Outlook

• Liquid Antacids
• Tablet Antacids
• Powder Antacids
• Chewable Antacids

Antacid Market Active Ingredient Outlook

• Aluminum Hydroxide
• Magnesium Hydroxide
• Sodium Bicarbonate
• Calcium Carbonate
• Potassium Citrate

Antacid Market Application Outlook

• Immediate Relief
• Long-Term Relief
• Heartburn
• Indigestion
• Acid Reflux

Antacid Market Distribution Channel Outlook

• Pharmacies
• Online Retailers
• Supermarkets
• Convenience Stores
• Healthcare Professionals

Antacid Market Regional Outlook

• North America
• Europe
• South America
• Asia Pacific
• Middle East and Africa

Report Attribute/Metric	Details
Market Size 2023	18.23(USD Billion)
Market Size 2024	18.99(USD Billion)
Market Size 2032	24.35(USD Billion)
Compound Annual Growth Rate (CAGR)	2.80% (2024 - 2032)
Report Coverage	Revenue Forecast, Competitive Landscape, Growth Factors, and Trends
Base Year	2023
Market Forecast Period	2024 - 2032
Historical Data	2019 - 2023
Market Forecast Units	USD Billion
Key Companies Profiled	Teva Pharmaceutical Industries Ltd., Johnson Johnson Consumer Inc., Bayer AG, Merck Co., Inc., Procter Gamble Company, GlaxoSmithKline plc, Mentholatum Company, In, Reckitt Benckiser, Daiichi Sankyo Company, Limited, AstraZeneca Plc, Sanofi Aventis, Abbott Laboratories, Novartis, Boehringer Ingelheim GmbH
Segments Covered	Type, Active Ingredient, Application, Distribution Channel, Regional
Key Market Opportunities	Growing consumer awareness, increasing prevalence of digestive disorders, expanding product portfolios, rising demand for natural and organic antacids, technological advancements
Key Market Dynamics	Rising prevalence of gastroesophageal reflux disease, increasing demand for over-the-counter medications, growing awareness of antacids, technological advancements expanding the elderly population
Countries Covered	North America, Europe, APAC, South America, MEA